Lignospan

Epinephrine and Lidocaine Hydrochloride, the active ingredients in Lignospan, are a local anesthetic presented as a solution for periodontal use. It provides rapid, localized anesthesia for dental procedures and is employed in adult patients undergoing periodontal surgery.

GNH USA supplies Lignospan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lignospan is a combination local anesthetic used in the dental field to achieve profound numbness during procedures. - Periodontal procedures: provides localized anesthesia to facilitate tissue manipulation and scaling. - Dental extractions: enables painless removal of teeth by blocking nerve transmission. - Minor oral surgery: offers rapid onset of numbness for incision and suturing in the oral cavity.

Lignospan may cause a range of adverse reactions, most of which are related to its local anesthetic and vasoconstrictive components.

Common Side Effects: - Transient burning or stinging at the injection site. - Mild dizziness or light‑headedness. - Temporary increase in heart rate. - Localized swelling or bruising. - Nausea or mild headache.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis) with rash, swelling, or airway compromise. - Cardiac arrhythmias or hypertension due to epinephrine excess. - Central nervous system toxicity such as seizures. - Persistent numbness or paresthesia beyond the expected duration. - Methemoglobinemia (rare) presenting with cyanosis.

When using Lignospan, clinicians should observe several safety measures to minimize risks. - Patient assessment: review cardiovascular history and allergy status before administration. - Dose limitation: avoid exceeding recommended maximum lidocaine dose for the patient. - Monitoring: observe vital signs after injection, especially in patients with cardiac disease. - Interaction awareness: consider concomitant sympathomimetic drugs that may amplify epinephrine effects. - Storage: Store at ambient temperature below 25°C: keep in original container, protect from moisture and direct sunlight.

Lignospan can interact with other medications, altering its safety profile.

Major Interactions (Avoid): - Non‑selective beta‑blockers: may potentiate bradycardia and hypotension. - Monoamine oxidase inhibitors (MAOIs): increase risk of hypertensive crisis. - Tricyclic antidepressants: can enhance lidocaine toxicity.

Moderate Interactions (Monitor Closely): - Sympathomimetic agents (e.g., pseudoephedrine): may augment epinephrine‑induced tachycardia. - Calcium channel blockers: may affect cardiac response to epinephrine. - Other local anesthetics: cumulative lidocaine exposure should be tracked.